MedTrace Logo

Development of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy

NCT04041089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-03-22

No results posted yet for this study

Summary

Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders.

The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.

Conditions

  • Posterior Cortical Atrophy

Interventions

BEHAVIORAL

Recognition of objects

* Name of shapes / colors / images / objects * Classification of shapes / colors / images / objects

BEHAVIORAL

Location of objects

* Search for frequent/rarse targets among distractors sharing one or more characteristics with the target * Hit/catch a stationary/mobile target as quickly as possible

BEHAVIORAL

Manipulation of objects

* Storage of shapes/objects * Use of everyday objects (pen, cutlery, etc.)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • MOUTON Aurélie, Ph · Centre Hospitalier Universitaire de Nice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2021-06-15
Completion
2022-06-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04041089 on ClinicalTrials.gov